These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
576 related items for PubMed ID: 30337921
21. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma. Aubier M, Wettenger R, Gans SJ. Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239 [Abstract] [Full Text] [Related]
22. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Hauber H, Taha R, Bergeron C, Migounov V, Hamid Q, Olivenstein R. Can Respir J; 2006 Mar; 13(2):73-8. PubMed ID: 16550263 [Abstract] [Full Text] [Related]
23. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ. Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480 [Abstract] [Full Text] [Related]
25. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P. Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [Abstract] [Full Text] [Related]
30. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM. Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [Abstract] [Full Text] [Related]
31. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL. J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004 [Abstract] [Full Text] [Related]
32. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis. Takeno S, Taruya T, Ueda T, Noda N, Hirakawa K. Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830 [Abstract] [Full Text] [Related]
33. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Wolthers OD, Walters EG. Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529 [Abstract] [Full Text] [Related]
34. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times. Leach CL, Colice GL. J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669 [Abstract] [Full Text] [Related]